This inventor holds 2 USPTO granted patents. Top assignee: Genelabs Technologies, Inc.. Active years: 2003-2006.
Company Filing History:
Years Active: 2003-2006
Title: Innovations by Marc J Gurwith
Introduction
Marc J Gurwith is a notable inventor based in Los Altos, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations involving dehydroepiandrosterone (DHEA). With a total of 2 patents to his name, Gurwith's work has implications for therapeutic applications.
Latest Patents
Gurwith's latest patents include a composition and method for DHEA. This invention discloses improved pharmaceutical formulations comprising DHEA, enriched in selected polymorphic forms for therapeutic applications. In one embodiment, the formulation comprises, in solid form, DHEA, at least 85% of which is present as a single polymorph selected from the form I polymorph or the form II polymorph, along with at least one pharmaceutical excipient. Additionally, he has developed a method for treating systemic lupus erythematosus (SLE) with DHEA, along with a related pharmaceutical product.
Career Highlights
Marc J Gurwith has been associated with Genelabs Technologies, Inc., where he has contributed to innovative research and development in the pharmaceutical sector. His work has focused on enhancing the efficacy of DHEA formulations, which are crucial for various therapeutic applications.
Collaborations
Gurwith has collaborated with notable colleagues, including Kenneth E Schwartz and Maxine B Yonker, to advance his research and patent applications.
Conclusion
Marc J Gurwith's contributions to the field of pharmaceuticals through his patents on DHEA formulations highlight his innovative spirit and dedication to improving therapeutic options. His work continues to influence the industry and offers promising avenues for future research.